In non-small cell lung cancer (NSCLC), HMGB1 levels in sera of 145 patients were significantly higher than in patients with chronic obstructive pulmonary disease (n = 77) and 49 healthy donors. This evidence concerns the gene HMGB1 and non-small cell lung carcinoma.